Advantage of transurethral resection with narrow band imaging for non-muscle invasive bladder cancer

Oncology Letters

Volumn 10, Issue 2, 2015, Pages 1097-1102

  Kobatake, Kohei ^a   Mita, Koji ^a   Ohara, Shinya ^a   Kato, Masao ^a  

^a HIROSHIMA CITY ASA HOSPITAL   (Japan)

Author keywords

Bladder cancer; Narrow band imaging; Transurethral resection

Indexed keywords

AGED; ARTICLE; BIOPSY; CANCER STAGING; CARCINOMA IN SITU; CYSTOSCOPY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NARROW BAND IMAGING; NON MUSCLE INVASIVE BLADDER CANCER; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; TRANSURETHRAL RESECTION; TUMOR RECURRENCE; TUMOR VOLUME; WHITE LIGHT IMAGING;

EID: 84931337103     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2015.3280     Document Type: Article

References (17)

1. Olympus, News release, December 26, 2006, Endoscopic videoscope system: http://www.olympus-europa.com/medical/en/medical_systems/applications/urology/bladder/narrow_band_imaging__nbi_/narrow_band_imaging__nbi_.html (Accessed April 22, 2015).
2. Hirata I, Nakagawa Y, Ohkubo M, Yahagi N and Yao K: Usefulness of magnifying narrow-band imaging endoscopy for the diagnosis of gastric and colorectal lesions. Digestion 85: 74-79, 2012.
3. Bryan RT, Billingham LJ and Wallace DM: Narrow-band imaging flexible cystoscopy in the detection of recurrent urothelial cancer of the bladder. BJU Int 101: 702-706, 2008.
4. Naselli A, Introini C, Timossi L, et al: A randomized prospective trial to assess the impact of transurethral resection in narrow band imaging modality on non-muscle-invasive bladder cancer recurrence. Eur Urol 61: 908-913, 2012.
5. Cauberg EC, Mamoulakis C, de la Rosette JJ and de Reijke TM: Narrow band imaging-assisted transurethral resection for non-muscle invasive bladder cancer significantly reduces residual tumor rate. World J Urol 29: 503-509, 2011.
6. Naselli A, Introini C, Bertolotto F, Spina B and Puppo P: Narrow band imaging for detecting residual/recurrent cancerous tissue during second transurethral resection of newly diagnosed non-muscle-invasive high-grade bladder cancer. BJU Int 105: 208-211, 2010.
7. Tatsugami K, Kuroiwa K, Kamoto T, et al: Evaluation of narrow-band imaging as a complementary method for the detection of bladder cancer. J Endourol 24: 1807-1811, 2010.
8. Cauberg EC, Kloen S, Visser M, et al: Narrow band imaging cystoscopy improves the detection of non-muscle-invasive bladder cancer. Urology 76: 658-663, 2010.
9. Herr HW and Donat SM: A comparison of white-light cystoscopy and narrow-band imaging cystoscopy to detect bladder tumour recurrences. BJU Int 102: 1111-1114, 2008.
10. Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Böhle A, Palou-Redorta J; European Association of Urology (EAU): EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol 54: 303-314, 2008.
11. Brausi M, Collette L, Kurth K, van der Meijden AP, et al; EORTC Genito-Urinary Tract Cancer Collaborative Group: Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: A combined analysis of seven EORTC studies. Eur Urol 41: 523-531, 2002.
12. Brausi M: Are new technologies for detection and treatment of non-muscle-invasive bladder cancer (NMIBC) so important? A plea for adoption by teaching programs to improve results after standard white light transurethral resection of NMIBC. Eur Urol 61: 914-916, 2012.
13. Sylvester RJ, van der Meijden AP, Oosterlinck W, et al: Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49: 466-477, 2006.
14. Daniltchenko DI, Riedl CR, Sachs MD, et al: Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study. J Urol 174: 2129-2133, 2005.
15. Schumacher MC, Holmäng S, Davidsson T, Friedrich B, Pedersen J and Wiklund NP: Transurethral resection of non-muscle-invasive bladder transitional cell cancers with or without 5-aminolevulinic acid under visible and fluorescent light: results of a prospective, randomised, multicentre study. Eur Urol 57: 293-299, 2010.
16. Clinical Research Office of the Endourological society, The Global Randomized NBI Bladder Cancer study: http://www.croesoffice.org/OngoingProjects/NBIStudy.aspx
17. Botteman MF, Pashos CL, Radaelli A, Laskin B and Hauser R: The health economics of bladder cancer: A comprehensive review of the published literature. Pharmacoeconomics 21: 1315-1330, 2003.